Bio-Connect

IL-6 ELISA

Research Use Only
BI-IL6
Biomedica
Assay Sample Typeserum, plasma (EDTA, citrate, heparin), cell culture supernatants, urine
Product group Assays
Price on request
96 tests
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    Biomedica
  • Product Name
    Human IL-6 ELISA
  • Delivery Days Customer
    7
  • Applications
    ELISA
  • Applications Supplier
    ELISA
  • Assay Detection Range
    3.12-200 pg/ml
  • Assay Precision
    intra-assay: 3%, inter-assay: 10%
  • Assay Sample Type
    serum, plasma (EDTA, citrate, heparin), cell culture supernatants, urine
  • Assay Sensitivity
    0.28 pg/ml
  • Assay Specificity
    human IL-6
  • Assay Test Principle
    Sandwich ELISA
  • Assay Time
    4.5h
  • Category Supplier
    Assay
  • Certification
    Research Use Only
  • Scientific Description
    Product Characteristics: The Biomedica IL-6 Sandwich ELISA kit is a test that is intended for the quantitative measurement of IL-6 levels in human serum and plasma samples. Target Information: Interleukin-6 (IL-6), also known as B-cell stimulatory factor 2 (BSF-2), CTL differentiation factor (CDF), Hybridoma growth factor or Interferon beta-2 (IFN-beta-2), is built up by 183 amino acids and has a calculated molecular weight of 23.7 kDa. The gene is mapped at chromosome 7p21. It is a pleiotropic, alpha helical protein that is composed of a four-helix bundle (Somers W et al.). IL-6 is phosphorylated at amino acid 81 and it is variably glycosylated by N-linked glycosylation. IL-6 belongs to the IL-6/GCSF/MGF protein family (Rose-John S et al.) whose members share a common use of the gp130 receptor subunit. IL-6 isoforms, with internal deletions, are generated by alternative splicing. The principal cell sources for IL-6 are mononuclear phagocytes, vascular endothelial cells, fibroblasts or other cells. IL-6 is the ligand for the Interleukin-6 receptor alfa (IL-6R alfa) (Schwantner A et al.) that occurs membrane-bound, but that may also circulate as soluble form generated by alternative splicing or proteolytic cleavage. To induce signaling, IL-6 first forms a complex with the non-signaling IL-6R alfa. Subsequent binding to the signal transducing subunit gp130 leads to dimerization of gp130 and finally to the formation of the hexameric signaling complex (Boulanger MJ et al.). Complexes of IL-6 and soluble IL-6R alfa may elicit responses in cells lacking the membrane-bound IL-6R alfa but expressing the ubiquitous gp130 coreceptor. This process is known as trans-signaling, it enlarges the spectrum of target cells responding to IL-6 (Mihara M et al.).
  • Storage Instruction
    2-8°C
  • UNSPSC
    41116133

References

  • Biomedica citations for human Interleukin-6 (IL-6) ELISA, BI-IL6
    Read more